Nurix Therapeutics Inc. (NRIX)
Market Closed
10 Sep, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
25. 81
-0.45
-1.7136%
Pre Market
$
+2.19 +8.4851% 28. 00
2.71B Market Cap
- P/E Ratio
- Div Yield
1.03M Volume
-2.91 Eps
$ 26.26
Previous Close 
Want to track NRIX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Nurix Therapeutics Inc. (NRIX) Statistics
Valuation metrics
Market Cap 2.71B
Enterprise value 2.7B
Trailing P/E (ttm) -7.58
Forward P/E -
PEG ratio 0.29
Price/Sales (ttm) 73.79
Price/Book (mrq) 7.21
Enterprise Value/Revenue 73.53
Enterprise Value/EBITDA -8.45
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.23M
Average volume (90 days) 1.92M
Price summary
52-Week low 8.2
52-Week high 28.23
Beta -
50-Day moving average 24.66
200-Day moving average 17.21
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -9.28%
Operating margin -9.82%
Operational effectiveness
Return on assets -0.64%
Return on equity -0.76%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.33
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -3.07
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 3.99
Total debt (mrq) -
Total Debt/Equity (mrq) 0.14
Current ratio (mrq) 6.34%
Book value per share (mrq) 3.62
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
